Overview BOTOX® Intravesical Instillation in Participants With Overactive Bladder and Urinary Incontinence Status: Completed Trial end date: 2020-07-21 Target enrollment: Participant gender: Summary This study will evaluate the efficacy and safety of BOTOX® intravesical instillation in participants with overactive bladder and urinary incontinence. Phase: Phase 2 Details Lead Sponsor: AllerganTreatments: abobotulinumtoxinABotulinum ToxinsBotulinum Toxins, Type AonabotulinumtoxinA